Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Snoeck

Showing results (11-20 of 255) with videos related to

Pageof 26
Sort By:
Idrugs : the Investigational Drugs Journal|March 2, 2010
Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infectionSophie Duraffour, Graciela Andrei, Robert Snoeck
Molecules (Basel, Switzerland)|March 16, 2019
Novel Therapeutics for Epstein⁻Barr VirusGraciela Andrei, Erika Trompet, Robert Snoeck
Infectious Disorders Drug Targets|March 12, 2009
Drug targets in cytomegalovirus infectionGraciella Andrei, Erik De Clercq, Robert Snoeck
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2008
Novel inhibitors of human CMVGraciela Andrei, Eric De Clercq, Robert Snoeck
Virus Evolution|December 24, 2024
Combined use of pritelivir with acyclovir or foscarnet suppresses evolution of HSV-1 drug resistanceHanna Helena Schalkwijk, Graciela Andrei, Robert Snoeck
Biochemical Pharmacology|October 29, 2022
Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternativesHanna H Schalkwijk, Robert Snoeck, Graciela Andrei
Tumour Virus Research|August 25, 2022
Synergistic targeting of the PI3K/mTOR and MAPK/ERK pathways in Merkel cell carcinomaArturo Temblador, Dimitrios Topalis, Graciela Andrei, et al.
Antiviral Research|September 28, 2011
Camelpox virusSophie Duraffour, Hermann Meyer, Graciela Andrei, et al.
Viruses|November 26, 2014
KSHV targeted therapy: an update on inhibitors of viral lytic replicationNatacha Coen, Sophie Duraffour, Robert Snoeck, et al.
The Journal of Infectious Diseases|November 30, 2017
The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA PolymeraseGraciela Andrei, Sarah Gillemot, Dimitrios Topalis, et al.
Pageof 26

Showing results (11-20 of 255) with videos related to

Sort By:
Pageof 26
Idrugs : the Investigational Drugs Journal|March 2, 2010
Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infectionSophie Duraffour, Graciela Andrei, Robert Snoeck
Molecules (Basel, Switzerland)|March 16, 2019
Novel Therapeutics for Epstein⁻Barr VirusGraciela Andrei, Erika Trompet, Robert Snoeck
Infectious Disorders Drug Targets|March 12, 2009
Drug targets in cytomegalovirus infectionGraciella Andrei, Erik De Clercq, Robert Snoeck
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2008
Novel inhibitors of human CMVGraciela Andrei, Eric De Clercq, Robert Snoeck
Virus Evolution|December 24, 2024
Combined use of pritelivir with acyclovir or foscarnet suppresses evolution of HSV-1 drug resistanceHanna Helena Schalkwijk, Graciela Andrei, Robert Snoeck
Biochemical Pharmacology|October 29, 2022
Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternativesHanna H Schalkwijk, Robert Snoeck, Graciela Andrei
Tumour Virus Research|August 25, 2022
Synergistic targeting of the PI3K/mTOR and MAPK/ERK pathways in Merkel cell carcinomaArturo Temblador, Dimitrios Topalis, Graciela Andrei, et al.
Antiviral Research|September 28, 2011
Camelpox virusSophie Duraffour, Hermann Meyer, Graciela Andrei, et al.
Viruses|November 26, 2014
KSHV targeted therapy: an update on inhibitors of viral lytic replicationNatacha Coen, Sophie Duraffour, Robert Snoeck, et al.
The Journal of Infectious Diseases|November 30, 2017
The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA PolymeraseGraciela Andrei, Sarah Gillemot, Dimitrios Topalis, et al.
Pageof 26